Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Officials are waiting for test results from a few preliminary, potential H5N1 cases over the last day or so in Central and ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

MRNA intends to use the funds to support the development of its mRNA-based bird flu shot and expand clinical studies for ...

The U.S. Department of Health and Human Services announced it will award $590 million to Moderna to accelerate the ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Merck stands to lose $62 billion over four years following the loss of exclusivity on KEYTRUDA, making Moderna's $13 billion market cap a bargain. The worsening Avian Flu crisis adds optionality ...